89bio, Inc. (ETNB)
Oct 30, 2025 - ETNB was delisted (reason: acquired by RHHBY)
14.84
0.00 (0.00%)
Inactive · Last trade price on Oct 29, 2025
89bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -174.61 | -142.19 | -102.03 | -90.12 | -49.5 | -57.42 |
Depreciation & Amortization | 0.05 | 0.05 | 0.07 | 0.08 | 0.06 | 0.02 |
Stock-Based Compensation | 18.59 | 16.11 | 10.36 | 8.68 | 3.81 | 0.39 |
Other Adjustments | -8.22 | -3.81 | -0.04 | 1.33 | 0.43 | 30.62 |
Changes in Accounts Payable | 6.87 | -3.92 | 5.66 | 4.78 | 1.13 | -0.52 |
Changes in Accrued Expenses | 3.35 | 7.88 | 1.75 | 4.15 | 1.43 | 3.45 |
Changes in Other Operating Activities | -15.55 | -3.3 | 3.15 | -5.67 | -3.6 | -1.99 |
Operating Cash Flow | -165.54 | -129.19 | -81.09 | -76.78 | -46.24 | -25.46 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | - | -0 | -0.01 | -0.06 | -0.13 | -0.14 |
Purchases of Investments | -390.71 | -341.15 | -152.7 | -141.2 | -118.9 | - |
Proceeds from Sale of Investments | 313.34 | 218.13 | 118.76 | 148.42 | 12.19 | - |
Investing Cash Flow | -77.37 | -123.02 | -33.94 | 7.16 | -106.83 | -0.14 |
Long-Term Debt Issued | - | 24.36 | - | 19.95 | - | - |
Long-Term Debt Repaid | - | -21.4 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | 2.96 | - | 19.95 | - | - |
Issuance of Common Stock | 0.18 | 512.42 | 118.13 | 3.92 | 158.09 | 87.7 |
Repurchase of Common Stock | -3.31 | -2.28 | -0.3 | - | - | - |
Net Common Stock Issued (Repurchased) | -3.13 | 510.15 | 117.83 | 3.92 | 158.09 | 87.7 |
Issuance of Preferred Stock | - | - | - | - | - | 20 |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | 20 |
Other Financing Activities | - | - | - | - | -0.16 | - |
Financing Cash Flow | 209.68 | 513.11 | 117.83 | 23.87 | 157.92 | 107.7 |
Net Cash Flow | -33.22 | 260.91 | 2.8 | -45.75 | 4.85 | 82.1 |
Beginning Cash & Cash Equivalents | 245.44 | 55.26 | 52.46 | 98.21 | 93.36 | 11.26 |
Ending Cash & Cash Equivalents | 212.22 | 316.16 | 55.26 | 52.46 | 98.21 | 93.36 |
Free Cash Flow | -165.54 | -129.19 | -81.1 | -76.84 | -46.37 | -25.6 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.88 | -1.82 | -2.33 | -3.82 | -2.88 | -10.92 |
Levered Free Cash Flow | -179.89 | -138.52 | -91.41 | -66.9 | -50.61 | -56.61 |
Unlevered Free Cash Flow | -201.14 | -154.73 | -91.65 | -86.33 | -50.46 | -25.83 |